Загрузка...
Inhibiting HTLV-1 Protease: A Viable Antiviral Target
Human T-cell lymphotropic virus type 1 (HTLV-1) is a retrovirus that can cause severe paralytic neurologic disease and immune disorders as well as cancer. An estimated 20 million people worldwide are infected with HTLV-1, with prevalence reaching 30% in some parts of the world. In stark contrast to...
Сохранить в:
| Опубликовано в: : | ACS Chem Biol |
|---|---|
| Главные авторы: | , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8126997/ https://ncbi.nlm.nih.gov/pubmed/33619959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acschembio.0c00975 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|